Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.43 |
| ▸ | LTA4H | P09960 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.43 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | PLAU | P00749 | 1/20 | 0.41 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | FURIN | P09958 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11613225 | 0.95 | KCNA3 (0.52) | KCNA3PRSS1L3MBTL1TMPRSS2PRMT1 | |
| SCHEMBL221617 | 0.92 | CYP3A4 (0.50) | KCNA3 | |
| SCHEMBL11615899 | 0.92 | KCNA3 (0.55) | KCNA3PRSS1L3MBTL1TMPRSS2PRMT1 | |
| SCHEMBL2015358 | 0.90 | DRD4 (0.52) | LTA4HL3MBTL1DRD2DRD4DRD3 | |
| SCHEMBL14095592 | 0.89 | PRMT1 (0.54) | KCNA3PRSS1L3MBTL1TMPRSS2PRMT1 | |
| SCHEMBL4692348 | 0.88 | LTA4H (0.59) | LTA4HDRD2DRD4DRD3 | |
| SCHEMBL6626845 | 0.88 | DRD2 (0.59) | L3MBTL1DRD2DRD4DRD3KDM4E | |
| SCHEMBL4218226 | 0.88 | DRD2 (0.52) | L3MBTL1DRD2DRD4DRD3ALDH1A1 | |
| SCHEMBL4754349 | 0.88 | DRD4 (0.55) | DRD2DRD4DRD3ALDH1A1SMN1; SMN2 | |
| SCHEMBL8315461 | 0.88 | KCNA3 (0.41) | KCNA3PRSS1LTA4HL3MBTL1TMPRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113578380-B | Column [5] arene ionic liquid catalyst based on propylimidazole functionalization and preparation method thereof | 抚顺东科新能源科技有限公司 | 2022-07-22 | — | — | CN | claimed |
| US-11845906-B2 | Fluorine-containing ether compound, lubricant for magnetic recording medium and magnetic recording medium | RESONAC CORPORATION (JP) | 2023-12-19 | — | — | US | disclosed |
| CN-114450263-B | Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium | 株式会社力森诺科 | 2023-11-21 | — | — | CN | disclosed |
| US-20230365491-A1 | METHOD FOR INHIBITING OR DISRUPTING BIOFILM FORMATION, OR REDUCING BIOFILM | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2023-11-16 | — | — | US | disclosed |
| US-20230365491-A1 | METHOD FOR INHIBITING OR DISRUPTING BIOFILM FORMATION, OR REDUCING BIOFILM | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2023-11-16 | — | — | US | disclosed |
| US-20220380695-A1 | FLUORINE-CONTAINING ETHER COMPOUND, LUBRICANT FOR MAGNETIC RECORDING MEDIUM AND MAGNETIC RECORDING MEDIUM | SHOWA DENKO K.K. (JP) | 2022-12-01 | — | — | US | disclosed |
| US-11447485-B2 | Class of bifunctional compounds with quanternary ammonium salt structure | BEIJING SHOWBY PHARMACEUTICAL CO., LTD. (CN) | 2022-09-20 | — | — | US | disclosed |
| CN-113578380-B | Column [5] arene ionic liquid catalyst based on propylimidazole functionalization and preparation method thereof | 抚顺东科新能源科技有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-114450263-A | Fluorinated ether compound, lubricant for magnetic recording medium, and magnetic recording medium | 昭和电工株式会社 | 2022-05-06 | — | — | CN | disclosed |
| CN-110087729-B | Bifunctional compound with quaternary ammonium salt structure | 北京硕佰医药科技有限责任公司 | 2022-04-05 | — | — | CN | disclosed |
| EP-3334706-B1 | PILLARARENES AND USES THEREOF | UNIV RAMOT (IL) | 2020-09-30 | — | — | EP | disclosed |
| EP-3556435-A1 | CLASS OF BIFUNCTIONAL COMPOUNDS WITH QUATERNARY AMMONIUM SALT STRUCTURE | Beijing Showby Pharmaceutical Co., Ltd. (CN) | 2019-10-23 | — | — | EP | disclosed |
| US-9950980-B2 | Fluoropolyether compound, lubricant containing same, and magnetic disk | MORESCO CORPORATION (JP) | 2018-04-24 | — | — | US | disclosed |
| WO-2017025951-A1 | PILLARARENES AND USES THEREOF | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2017-02-16 | — | — | WO | disclosed |
| EP-3085684-A1 | FLUOROPOLYETHER COMPOUND, LUBRICANT CONTAINING SAME, AND MAGNETIC DISK | Moresco Corporation (JP) | 2016-10-26 | — | — | EP | disclosed |
| US-20160203839-A1 | FLUOROPOLYETHER COMPOUND, LUBRICANT CONTAINING SAME, AND MAGNETIC DISK | MORESCO CORPORATION (JP) | 2016-07-14 | — | — | US | disclosed |
| US-8632914-B2 | Triazolium and imidazolium salts and uses thereof | UNIVERSITY HEALTH NETWORK (CA) | 2014-01-21 | — | — | US | disclosed |
| US-20110257235-A1 | TRIAZOLIUM AND IMIDAZOLIUM SALTS AND USES THEREOF | UNIVERSITY HEALTH NETWORK (CA) | 2011-10-20 | — | — | US | disclosed |
| US-4209526-A | Antiviral arylenedioxyalkyl substituted pyrazoles | STERLING DRUG INC. (US) | 1980-06-24 | — | — | US | disclosed |
| US-4171365-A | Antiviral aryloxyalkylpyrazoles | STERLING DRUG INC. (US) | 1979-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11447485-B2 | Class of bifunctional compounds with quanternary ammonium salt structure | AGTR2, AGTR1, ADRB2 | KCNA3 94/4885PRSS1 4083/4885LTA4H 682/4885 |
| US-20110257235-A1 | TRIAZOLIUM AND IMIDAZOLIUM SALTS AND USES THEREOF | ARG2, ARG1, CIT | KCNA3 1561/4885PRSS1 3195/4885LTA4H 3717/4885 |
| US-20230365491-A1 | METHOD FOR INHIBITING OR DISRUPTING BIOFILM FORMATION, OR REDUCING BIOFILM | GNE, PGLS, ALG1 | KCNA3 1602/4885PRSS1 1919/4885LTA4H 3777/4885 |
| US-20160203839-A1 | FLUOROPOLYETHER COMPOUND, LUBRICANT CONTAINING SAME, AND MAGNETIC DISK | AFF2, F12, AFF4 | KCNA3 1748/4885PRSS1 3849/4885LTA4H 1884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.